Clinical Neuroscience Lab, Federal University of Sao Paulo, Sao Paulo, Brazil; Center for Neuromodulation Studies, Dep. of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil.
Clinical Neuroscience Lab, Federal University of Sao Paulo, Sao Paulo, Brazil; Center for Neuromodulation Studies, Dep. of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil.
Schizophr Res. 2018 May;195:591-593. doi: 10.1016/j.schres.2017.08.044. Epub 2017 Sep 5.
Cognitive impairments in schizophrenia are strongly correlated to functional outcome and recovery rates, with no pharmacological agent approved for its treatment. Neurofeedback has emerged as a non-pharmacological approach to enhance neuroplasticity, which consists in inducing voluntary control of brain responses through operant conditioning.
The effects of hemoencephalography neurofeedback (HEG-NFBK) in 4 brain sites (F7, Fp1, Fp2 and F8) was studied in 8 patients with schizophrenia (SCH, mean age 36.5±9.98) and 12 health controls (mean age 32.17±5.6). We analyzed groups' performance (10 sessions) and cognitive differences in 3 time points (baseline, after training and follow-up) with generalized estimated equations. For SCH we also evaluate the impact on psychopathology.
We found a group∗time interaction for HEG-NFBK performance in the left hemisphere sites (F7 an Fp1) and a near-to-significant in the right frontotemporal region (F8), with no group differences and a significant time effect. Most of cognitive domains improved after intervention, including information processing speed, attention processing, working memory, executive functioning, verbal and visual learning. No group∗time interaction was found. Results suggest that both groups benefit from HEG-NFBK training regardless of cognitive differences at baseline. No significant time effects were found for Calgary and PANSS total scale and subscales (positive, negative neither general).
To our knowledge, this is the first controlled trial showing effects of NFBK on cognitive performance improvement in schizophrenia. Further research investigating the effects of HEG-NFBK training in schizophrenia should be performed.
精神分裂症患者的认知障碍与功能结果和恢复率密切相关,目前尚无药物可用于治疗。神经反馈已成为一种增强神经可塑性的非药物方法,通过操作性条件作用来诱导对大脑反应的自愿控制。
研究了 8 名精神分裂症患者(SCH,平均年龄 36.5±9.98 岁)和 12 名健康对照者(平均年龄 32.17±5.6 岁)在 4 个脑区(F7、Fp1、Fp2 和 F8)进行的脑电图神经反馈(HEG-NFBK)的效果。我们使用广义估计方程分析了两组在三个时间点(基线、训练后和随访)的表现(10 次)和认知差异。对于 SCH,我们还评估了对精神病理学的影响。
我们发现 HEG-NFBK 表现的组间时间交互作用在左侧半球部位(F7 和 Fp1),在右侧额颞区接近显著(F8),但组间无差异,且时间效应显著。干预后大多数认知域均得到改善,包括信息处理速度、注意力处理、工作记忆、执行功能、言语和视觉学习。未发现组间时间交互作用。结果表明,两组均受益于 HEG-NFBK 训练,而与基线时的认知差异无关。Calgary 和 PANSS 总分和子量表(阳性、阴性和一般)均未发现显著的时间效应。
据我们所知,这是第一项表明神经反馈对精神分裂症认知表现改善有作用的对照试验。应该进行进一步的研究,以调查 HEG-NFBK 训练对精神分裂症的影响。